Login / Signup

Outcomes Associated With Levetiracetam Use After Spontaneous Intracerebral Hemorrhage.

Mary Stewart LeatherwoodLeslie A HamiltonJacob BarberAnthony Shaun Rowe
Published in: The Neurohospitalist (2023)
This study does not support the use of levetiracetam prophylaxis in patients who have experienced an ICH.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • brain injury
  • peritoneal dialysis
  • type diabetes
  • patient reported outcomes
  • metabolic syndrome
  • insulin resistance
  • skeletal muscle